• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconOncology

Oncology

Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in overall survival in people with germline BRCA-mutated (gBRCAm), HER2-negative high-risk early breast cancer, 2024 clinical trial data suggest.
Health
Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
By Lindsey LeakeDecember 20, 2024
Women embracing after finishing breast cancer awareness race.
Health
Scientists discover evidence of 4 more breast cancer genes—and potentially many others: ‘The risks can be significant for women who carry them’
By Erin PraterAugust 17, 2023
A woman in an Allcyte lab coat looking at images of cancer cells on a screen.
Tech
British A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company
By Jeremy KahnJune 15, 2021
Microscopy image of cancer cells
Tech
This startup has found a way to uncover bespoke cancer therapies
By Jeremy KahnMarch 25, 2021
A line of syringes shown in silhouette against the AstraZeneca corporate logo.
Finance
AstraZeneca’s stock is soaring on COVID, but the pandemic has dented its growth
By Jeremy KahnNovember 6, 2020
How reborn pharma giant AstraZeneca is taking the lead against COVID-19
Magazine
How reborn pharma giant AstraZeneca is taking the lead against COVID-19
By Jeremy KahnAugust 10, 2020
Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
Health
Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
By Riley Griffin, James Paton and BloombergDecember 9, 2019
How to Innovate at Flatiron Health? It Starts With a Hackathon
Health
How to Innovate at Flatiron Health? It Starts With a Hackathon
By Andrew NuscaJuly 31, 2018
Gilead Takes AIDS Drug-Cocktail Approach To Fighting Cancer
Health
Gilead’s New Cancer Gene Therapy Has Been Approved by the FDA
By ReutersOctober 18, 2017
2017 Newport Folk Festival
Leadership
Here Are This Year’s MacArthur ‘Genius’ Grant Winners
By Natasha BachOctober 11, 2017
Kim Le, a research associate for FivePrime Therapeutics, wor
Health
This Obscure Biotech Company May Have a Game-Changing Cancer Med On Its Hands
By Sy MukherjeeJune 6, 2016
pancreatic cancer cell
Tech
Study Finds Targeted Cancer Drugs May Work in Range of Tumor Types
By ReutersJune 4, 2016
Israeli Laboratory Leads Western World In Blood Testing
Tech
A Blood Test for Cancer Gets Closer
By TIMEJune 4, 2016
Chicago skyscrapers
Health
What You Need to Know About the World’s Biggest Cancer Conference
By Sy MukherjeeJune 2, 2016
This Microscope Can Detect Cancer Without a Biopsy
Health
This Microscope Can Detect Cancer Without a Biopsy
By Hilary BrueckJanuary 28, 2016
1
  • 1
  • 2
2
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.